Africa (WHO region) vs Marshall Islands: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Marshall Islands
100.0%
in 2019
Africa (WHO region) rank
2nd
Marshall Islands rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Marshall Islands
How they compare
Marshall Islands currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
Across all 5 years both countries report, Marshall Islands has been ahead every year.
Africa (WHO region) ranks 2nd and Marshall Islands ranks 1st of 11 groups.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 100.0% | 64.0% | Marshall Islands |
| 2010s | 73.5% | 100.0% | 26.5% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Marshall Islands?
- Marshall Islands, at 100.0% against 96.0% in Africa (WHO region) as of 2019.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Marshall Islands?
- 4.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Africa (WHO region) and Marshall Islands?
- 5 years are reported by both, from 2009 to 2019.
- How do Africa (WHO region) and Marshall Islands rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Marshall Islands ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.